Opticians May Soon Play a Role in Dementia Screening
A breakthrough in artificial intelligence (AI) technology could soon allow opticians to detect early signs of dementia during routine eye exams. By analyzing subtle changes in the retinal blood vessels, this technology offers a quick and non-invasive method to assess brain health. This AI innovation could help identify neurodegenerative conditions like Alzheimer’s disease earlier than traditional methods.
How AI Uses Eye Scans to Detect Cognitive Decline
The AI system, named Quartz, can process eye scans in mere seconds. It examines the size, shape, and twisting of small blood vessels in the retina, which are closely linked to the brain’s vascular system. Any abnormalities in these blood vessels could indicate a reduction in blood flow to the brain, which is often an early sign of dementia.
Researchers at City St George’s University of London studied over 63,000 people aged between 40 and 69, using the Quartz system. They compared eye scan data with cognitive test results that measured memory, reaction speed, and intelligence. The results showed that individuals with narrower or more irregular retinal blood vessels performed worse in cognitive tests. This suggests a strong link between eye health and brain function, supporting the idea that eye scans could be an effective tool for early dementia detection.
Early Detection Could Improve Diagnosis and Treatment
Experts believe that spotting changes in retinal blood vessels early could lead to the detection of dementia before symptoms become noticeable. This could allow for closer monitoring and earlier intervention, providing individuals at risk of developing neurodegenerative diseases a better chance at treatment.
Professor Chris Owen, the lead author of the study, emphasizes that this technology could soon become a part of routine optician visits. A simple eye scan might provide a fast and affordable way to flag individuals who could be at risk of dementia. The scan’s potential to detect early signs of brain health decline could dramatically improve early diagnosis and long-term outcomes.
David Thomas, a representative from Alzheimer’s Research UK, refers to this AI-driven eye scan method as a potential “gamechanger.” He explains that when paired with other diagnostic tools, such as brain imaging, eye scans could significantly improve the accuracy of dementia detection. This approach could ensure that patients receive timely treatment and support, making a significant difference in their quality of life.
The Path Toward Widespread Use
Though the technology is still in its early stages, researchers are optimistic about its future potential. The ability to detect dementia in its early stages through a simple eye scan could revolutionize the way we approach neurodegenerative diseases. Furthermore, by the time this AI-powered technology becomes common practice in opticians’ offices, new treatments for dementia may be available, enhancing the value of early diagnosis even further.
In the coming years, as this technology develops and becomes more widely available, it could offer a crucial tool in the fight against dementia. The hope is that these early eye scans could not only improve detection rates but also increase the effectiveness of treatment options by catching the disease in its earliest, most treatable stages.
For more on how AI is changing the landscape of healthcare, visit Wallstreet Storys.
